Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum
2023-01-03 23:25
Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office
2022-12-29 23:25
FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial
2022-12-22 20:30
Initial plan of development completed for Blue Star's world-class Las Animas helium project
2022-12-19 15:28
Oracle Teams Up With OneQode to Deliver Low-Latency Solutions Across Asia-Pacific
2022-12-15 22:00
AustralianSuper and Churchill Asset Management announce new lending partnership
2022-12-15 20:00
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
2022-12-14 21:52
Versius adopted for gynaecological and urogynaecological procedures at Frances Perry House
2022-12-13 07:00
Sapia.ai to invest in bringing the best kept secret in HR tech to America
2022-12-12 22:00
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)
2022-12-12 21:00
AETOS Capital Group Wins 2022 Best Forex Broker in Asia by Traders Awards
2022-12-12 12:13
Cavendish Renewable Technology Signs Agreement for Development of State-of-the-Art Hydrogen Electrolyser Technologies with Adani New Industries Limited
2022-12-09 12:37
HungryPanda Hosted the First Ever Global Chinese Food Delivery Industry Trend Summit
2022-12-09 10:11
Sapia.ai releases its independent disparate impact report by BLDS, LLC
2022-12-08 21:00
FlexRule recognized by Gartner for enabling companies to automate business decisions with Advanced Decision Management Suite
2022-12-07 10:14
Reward Gateway announces Nick Burns as new Chief Executive Officer
2022-12-05 15:00
World's First Carry On Luggage Stroller named a TIME's Best Inventions of the year
2022-11-29 03:00
Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia
2022-11-24 22:00
Denave Expands Global Footprint with New Delivery Center in Malaysia
2022-11-23 14:16
IND approval from the US FDA for theranostic SAR-Bombesin trial in prostate cancer
2022-11-21 22:04
1
11
12
13
14
15
113